AVOQ, LLC

Lobbying for NOVO NORDISK INC. · Pharmaceutical company

Filing 1st Quarter - Termination

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $20,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Issues related to obesity; Issues related to medication affordability and access

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem